Seeking Alpha

Charles River Laboratories Intl, Inc. (CRL)

()

Mike Havrilla: $ABIO / Arca biopharma submits study protocol to address FDA CRL for Gencaro, gene-defined heart failure patients / http://tinyurl.com/y9ebfcc

Tue, Dec 22, 2009
Link | Email | Tweet this
Mike Havrilla: $FCSC.OB / Fibrocell Science FDA CRL, requesting more safety data for cell-based wrinkle treatment (azficel-T) / http://tinyurl.com/yaouwzn

Tue, Dec 22, 2009
Link | Email | Tweet this
Mike Havrilla: $SNY / Sanofi-Aventis halts dev insomnia drug eplivanserin (Ciltyri) following FDA CRL 16-Sep, need4 more studies / http://tinyurl.com/yazs9nh

Mon, Dec 21, 2009
Link | Email | Tweet this
Mike Havrilla: $SOMX / Somaxon Pharma schedule to meet with FDA 20-Jan to discuss insomnia drug Silenor (doxepin) CRL / http://tinyurl.com/y8eqsqb

Thu, Dec 17, 2009
Link | Email | Tweet this
Mike Havrilla: $SOMX / Somaxon Pharma Down 65% Pre-Mkt / FDA Issues CRL for Silenor (doxepin) insomnia NDA / http://biomedreports.com

Mon, Dec 07, 2009
Link | Email | Tweet this
Mike Havrilla: $ENDP / Endo Pharma / FDA Issues CRL for Aveed (Nebido) / long-acting testosterone replacement injection / http://bit.ly/51ZSaH

Thu, Dec 03, 2009
Link | Email | Tweet this
David White: Dyax has recently given back some of its run up. The shine is gone as this date is for action on the CRL. Avg. analyst rating 1.6. Up likely

Tue, Dec 01, 2009
Link | Email | Tweet this